Substance use during COVID-19 pandemic: impact on the underserved communities

Area of Science:

• Public Health
• Epidemiology
• Substance Use Disorders

Background:

• Global overdose deaths are rising, with an estimated 93,000 in the US in 2020.
• The COVID-19 pandemic has significantly worsened the existing drug crisis.
• Health disparities in underserved communities are exacerbated by the pandemic's impact on individuals with substance use disorder.

Purpose of the Study:

• To review and summarize the acute health effects of the COVID-19 pandemic on individuals with substance use disorder.
• To identify key factors contributing to the exacerbated health crisis.
• To highlight the need for policy and regulatory changes.

Main Methods:

• Literature review and synthesis of existing data.
• Analysis of factors contributing to acute health effects.
• Evaluation of the impact of the pandemic on substance use disorder treatment access.

Main Results:

• Factors like health disparities, limited treatment access, regulatory barriers in telehealth, and pandemic-related stress intensify the crisis.
• Underserved communities and people of color face disproportionately severe impacts.
• Existing disparities are amplified, leading to acute health effects.

Conclusions:

• Policy and regulatory changes are needed to improve telehealth and treatment access for substance use disorder.
• Evidence-based strategies and safer drug practices are essential to mitigate health impacts.
• Investment in treatment access and mental health services can reduce disparities and prepare for future health crises.